메뉴 건너뛰기
Blood
Volumn 116, Issue 8, 2010, Pages 1194-1196
PLDing a case for angiogenesis
Author keywords

[No Author keywords available]
Indexed keywords

BUTANOL; DIACYLGLYCEROL; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE D1; PROPRANOLOL; PROTEIN KINASE; PROTEIN KINASE C BETA; PROTEIN KINASE C GAMMA; PROTEIN KINASE C INHIBITOR; RAC PROTEIN; RHO FACTOR; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR;
EID: 77956554895     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-284117     Document Type: Note
Times cited : (1)
References (10)
  • 1
    • 77956556532 scopus 로고    scopus 로고
    • PLD1-dependent PKCgamma activation downstream to Src is essential for the development of pathologic retinal neovascularization
    • Zhang Q, Wang D, Kundumani-Sridharan V, et al. PLD1-dependent PKCgamma activation downstream to Src is essential for the development of pathologic retinal neovascularization. Blood. 2010;116(8):1377-1385.
    • (2010) Blood , vol.116 , Issue.8 , pp. 1377-1385
    • Zhang, Q.1    Wang, D.2    Kundumani-Sridharan, V.3
  • 2
    • 71849098262 scopus 로고    scopus 로고
    • It takes two to tango: Combinations of conventional cytotoxics with compounds targeting the vascular endothelial growth factor-vascular endothelial growth factor receptor pathway in patients with solid malignancies
    • Boere IA, Hamburg P, Sleijfer S. It takes two to tango: combinations of conventional cytotoxics with compounds targeting the vascular endothelial growth factor-vascular endothelial growth factor receptor pathway in patients with solid malignancies. Cancer Sci. 2010;101(1):7-15.
    • (2010) Cancer Sci , vol.101 , Issue.1 , pp. 7-15
    • Boere, I.A.1    Hamburg, P.2    Sleijfer, S.3
  • 3
    • 33644661269 scopus 로고    scopus 로고
    • Src family kinases as regulators of angiogenesis: Therapeutic implications
    • Lesslie III DP, Gallick GE. Src family kinases as regulators of angiogenesis: therapeutic implications. Curr Cancer Ther Rev. 2005;1:45-50.
    • (2005) Curr Cancer Ther Rev , vol.1 , pp. 45-50
    • Lesslie III, D.P.1    Gallick, G.E.2
  • 4
    • 34250702110 scopus 로고    scopus 로고
    • The role of protein kinase C activation and the vascular complications of diabetes
    • DOI 10.1016/j.phrs.2007.04.016, PII S1043661807000904
    • Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res. 2007;55(6):498-510. (Pubitemid 46962309)
    • (2007) Pharmacological Research , vol.55 , Issue.6 , pp. 498-510
    • Das Evcimen, N.1    King, G.L.2
  • 5
    • 0035895735 scopus 로고    scopus 로고
    • Platelet-released phospholipids link haemostasis and angiogenesis
    • DOI 10.1016/S0008-6363(00)00230-3, PII S0008636300002303
    • English D, Garcia JG, Brindley DN. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc Res. 2001;49(3):588-599. (Pubitemid 32146422)
    • (2001) Cardiovascular Research , vol.49 , Issue.3 , pp. 588-599
    • English, D.1    Garcia, J.G.N.2    Brindley, D.N.3
  • 6
    • 23644455714 scopus 로고    scopus 로고
    • Phospholipase D: A lipid centric review
    • Jenkins GM, Frohman MA. Phospholipase D: a lipid centric review. Cell Mol Life Sci. 2005;62(19-20):2305-2316.
    • (2005) Cell Mol Life Sci , vol.62 , Issue.19-20 , pp. 2305-2316
    • Jenkins, G.M.1    Frohman, M.A.2
  • 7
    • 63349108525 scopus 로고    scopus 로고
    • Phospholipase D1 is required for angiogenesis of intersegmental blood vessels in zebrafish
    • Zeng XX, Zheng X, Xiang Y, et al. Phospholipase D1 is required for angiogenesis of intersegmental blood vessels in zebrafish. Dev Biol. 2009;328(2):363-376.
    • (2009) Dev Biol , vol.328 , Issue.2 , pp. 363-376
    • Zeng, X.X.1    Zheng, X.2    Xiang, Y.3
  • 8
    • 0026783578 scopus 로고
    • Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C
    • Sozzani S, Agwu D, et al. Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C. J Biol Chem. 1992;267(28):20481- 20488.
    • (1992) J Biol Chem , vol.267 , Issue.28 , pp. 20481-20488
    • Sozzani, S.1    Agwu, D.2
  • 9
    • 62149152761 scopus 로고    scopus 로고
    • 5-Fluoro-2-indolyl deschlorohalopemide (FIPI), a phospholipase d pharmacological inhibitor that alters cell spreading and inhibits chemotaxis
    • Su W, Yeku O, Olepu S, et al. 5-Fluoro-2-indolyl deschlorohalopemide (FIPI), a phospholipase d pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol Pharmacol. 2009;75(3):437-446.
    • (2009) Mol Pharmacol , vol.75 , Issue.3 , pp. 437-446
    • Su, W.1    Yeku, O.2    Olepu, S.3
  • 10
    • 4444264480 scopus 로고    scopus 로고
    • Angiotensin II, cell proliferation and angiogenesis regulator: Biologic and therapeutic implications in cancer
    • DOI 10.2174/1570161043385556
    • Escobar E, Rodriguez-Reyna TS, Arrieta O, et al. Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr Vasc Pharmacol. 2004;2(4):385-399. (Pubitemid 39200189)
    • (2004) Current Vascular Pharmacology , vol.2 , Issue.4 , pp. 385-399
    • Escobar, E.1    Rodriguez-Reyna, T.S.2    Arrieta, O.3    Sotelo, J.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.